TotalMarketCap

Fulcrum Therapeutics

FULCNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$281.467 M

$3.69 -2.25%

Close of 6 Nov 2026

As of 6 Nov 2026, Fulcrum Therapeutics (FULC) has a market capitalization of $281.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$74.9M

Loss-making

Shares outstanding

76,297,257

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #220Enanta PharmaceuticalsENTA$294.2M
  2. #221Prelude TherapeuticsPRLD$283.7M
  3. #222Fulcrum TherapeuticsFULC$281.5M
  4. #223VogenxVOGX$273.8M
  5. #224Turn TherapeuticsTTRX$272.7M

What if Fulcrum Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$369,679.94

Per share 100,320× higher

Bitcoin $1.53T

$20,002.74

Per share 5,428× higher

Apple $5.02T

$65,667.12

Per share 17,820× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Fulcrum Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.